Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MSTR vs GSK✓SelectedUSD · GSKMSTR vs GSK performance historyLatest closeAs of-6.34%11/17
Stock and ETF performance explorer

MSTR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+388.7%
GSK return
+104.0%
Excess return
+284.7%
Maximum drawdown
-89.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.3%-2.3%-4.0%-5.7%
7D-20.3%-3.0%-17.3%-19.6%
30D-29.5%+0.4%-29.8%-29.6%
3M-1.2%-1.2%0.0%-1.2%
6M-45.6%+0.9%-46.5%-46.1%
YTD-36.5%+4.0%-40.5%-38.1%
1Y-50.6%+7.3%-57.9%-52.4%
3Y+98.5%+57.1%+41.4%+56.5%
5Y+28.2%+43.0%-14.8%+5.8%
10Y+388.7%+103.1%+285.6%+255.9%
All+388.7%+104.0%+284.7%+255.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling